Tag Archive for: clinicaldevelopment

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

/in

Financing led by Investissement Québec with continued support from long-standing investors Plans include the acceleration of clinical development of breakthrough GPCR targeting treatments for patients Montreal, Canada – Strasbourg, France – Boston, United States, February 10, 2026: Kainova Therapeutics (“the Company”), a key player for breakthrough treatments for patients in immuno-oncology and inflammation, today announced […]

Read more

SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program

/in

Dr. Favre brings extensive experience in gene therapy, immunology and drug development Appointment comes at a pivotal time of Company growth as it prepares for clinical development and expands its pipeline into other gene therapies  BARCELONA, June 20, 2023 – SpliceBio, a genetic medicines company exploiting its proprietary Protein Splicing platform to develop next generation […]

Read more